Neurology & Cognitive Health
Dementia
Dementia affects memory, thinking, behavior, and the ability to perform everyday activities. As the global aging population grows, the need for innovative dementia therapies and research continues to rise. CenExel partners with sponsors to advance clinical trials focused on improving cognitive function, slowing disease progression, and enhancing patient quality of life.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Dementia Clinical Research
CenExel provides specialized expertise in dementia and neurodegenerative clinical research, supporting studies from early-stage evaluations through late-phase trials. Our experienced investigators and operational teams focus on patient-centered care, accurate cognitive assessments, and efficient study execution to help accelerate therapeutic innovation.
Conditions Covered
Dementia Conditions We Research
Our dementia research programs support a broad range of neurodegenerative and cognitive disorders across adult and aging populations.
- Alzheimer’s Disease
- Vascular Dementia
- Lewy Body Dementia
- Agitation Associated with Dementia
- Mild Cognitive Impairment (MCI)
- Parkinson’s Disease Dementia
- Cognitive Decline Disorders
- Pediatric Anxiety Disorders
Our Approach
Why Sponsors Choose CenExel for Dementia Research
CenExel delivers scientific expertise, operational consistency, and access to diverse patient populations for dementia and cognitive health studies.
01
Cognitive Assessment Expertise
We support complex neurological studies with validated cognitive testing and experienced research staff.
02
Specialized Recruitment Strategy
Our sites utilize targeted outreach strategies to identify and enroll qualified dementia study participants.
03
Diverse Patient Populations
Our nationwide network helps ensure broad demographic representation in dementia clinical trials.
04
High-Quality Study Execution
CenExel maintains strong operational performance across all study phases, helping sponsors achieve reliable results.
Phase Coverage
Supported Dementia Trial Phases
CenExel supports dementia and neurodegenerative studies from first-in-human research through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our Dementia research network supports biomarker strategies, decentralized trial components, and patient-focused study execution for anxiety-related indications.
Dementia Task Force
CenExel supports dementia-focused clinical trials with experienced investigators, cognitive testing expertise, and specialized patient recruitment strategies across multiple research sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
